 JERUSALEM, Jan. 29, 2021 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the prevention and treatment of infectious diseases and related illnesses, today announced... 